Related references
Note: Only part of the references are listed.Effects of Inactivation of D,D-Transpeptidases of Acinetobacter baumannii on Bacterial Growth and Susceptibility to β-Lactam Antibiotics
Marta Toth et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)
Comparative efficacy and safety of combination therapy with high-dose sulbactam or colistin with additional antibacterial agents for multiple drug-resistant and extensively drug-resistant Acinetobacter baumannii infections: A systematic review and network meta-analysis
Jiating Liu et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2021)
Mechanistic Basis of OXA-48-like β-Lactamases' Hydrolysis of Carbapenems
Vlatko Stojanoski et al.
ACS INFECTIOUS DISEASES (2021)
In Crystallo Time-Resolved Interaction of the Clostridioides difficile CDD-1 enzyme with Avibactam Provides New Insights into the Catalytic Mechanism of Class D β-lactamases
Nichole K. Stewart et al.
ACS INFECTIOUS DISEASES (2021)
Comparative analysis of carbapenemases, RND family efflux pumps and biofilm formation potential among Acinetobacter baumannii strains with different carbapenem susceptibility
Yanpeng Zhang et al.
BMC INFECTIOUS DISEASES (2021)
Biocide resistance in Acinetobacter baumannii: appraising the mechanisms
E. S. Milani et al.
JOURNAL OF HOSPITAL INFECTION (2021)
Atypically Modified Carbapenem Antibiotics Display Improved Antimycobacterial Activity in the Absence of β-Lactamase Inhibitors
Rashmi Gupta et al.
ACS INFECTIOUS DISEASES (2021)
Acinetobacter baumannii Biofilm Formation and Its Role in Disease Pathogenesis: A Review
Alemu Gedefie et al.
INFECTION AND DRUG RESISTANCE (2021)
Acinetobacter baumannii Infections in Times of COVID-19 Pandemic
Karyne Rangel et al.
PATHOGENS (2021)
KPC-2 β-lactamase enables carbapenem antibiotic resistance through fast deacylation of the covalent intermediate
Shrenik C. Mehta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Colistin-Resistant Acinetobacter Baumannii Bacteremia: A Serious Threat for Critically Ill Patients
Georgios Papathanakos et al.
MICROORGANISMS (2020)
Analysis of β-lactone formation by clinically observed carbapenemases informs on a novel antibiotic resistance mechanism
Kristina M. J. Aertker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
Excess mortality due to pandrug-resistant Acinetobacter baumannii infections in hospitalized patients
S. Karakonstantis et al.
JOURNAL OF HOSPITAL INFECTION (2020)
Insights into Acinetobacter baumannii: A Review of Microbiological, Virulence, and Resistance Traits in a Threatening Nosocomial Pathogen
Carole Ayoub Moubareck et al.
ANTIBIOTICS-BASEL (2020)
OPLS3e: Extending Force Field Coverage for Drug-Like Small Molecules
Katarina Roos et al.
JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2019)
Structural Insights into the Mechanism of Carbapenemase Activity of the OXA-48 β-Lactamase
Clyde A. Smith et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
The global prevalence of multidrug-resistance among Acinetobacter baumannii causing hospital-acquired and ventilator-associated pneumonia and its associated mortality: A systematic review and meta-analysis
S. Mohd Sazlly Lim et al.
JOURNAL OF INFECTION (2019)
Role of the Hydrophobic Bridge in the Carbapenemase Activity of Class D β-Lactamases
Nichole K. Stewart et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis
Kirati Kengkla et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)
A New Mechanism for β-Lactamases: Class D Enzymes Degrade 1β-Methyl Carbapenems through Lactone Formation
Christopher T. Lohans et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
A focused fragment library targeting the antibiotic resistance enzyme - Oxacillinase-48: Synthesis, structural evaluation and inhibitor design
Sundus Akhter et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Conformational Intermediate That Controls KPC-2 Catalysis and Beta-Lactam Drug Resistance
George A. Cortina et al.
ACS CATALYSIS (2018)
The structure of a doripenem-bound OXA-51 class D β-lactamase variant with enhanced carbapenemase activity
Cynthia M. June et al.
PROTEIN SCIENCE (2016)
A Triple Mutant in the Ω-loop of TEM-1 β-Lactamase Changes the Substrate Profile via a Large Conformational Change and an Altered General Base for Catalysis
Vlatko Stojanoski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Kinetic and Structural Requirements for Carbapenemase Activity in GES-Type β-Lactamases
Nichole K. Stewart et al.
BIOCHEMISTRY (2015)
Class D β-Lactamases: Are They All Carbapenemases?
Nuno T. Antunes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Acquired Class D β-Lactamases
Nuno T. Antunes et al.
ANTIBIOTICS-BASEL (2014)
How good are my data and what is the resolution?
Philip R. Evans et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2013)
Structural Basis for Carbapenemase Activity of the OXA-23 β-Lactamase from Acinetobacter baumannii
Clyde A. Smith et al.
CHEMISTRY & BIOLOGY (2013)
Towards automated crystallographic structure refinement with phenix.refine
Pavel V. Afonine et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2012)
Antibiotic Resistance and Substrate Profiles of the Class A Carbapenemase KPC-6
Toni L. Lamoureaux et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
Yun Cai et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
An Amino Acid Position at Crossroads of Evolution of Protein Function ANTIBIOTIC SENSOR DOMAIN OF BlaR1 PROTEIN FROM STAPHYLOCOCCUS AUREUS VERSUS CLASS D β-LACTAMASES
Malika Kumarasiri et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Docking and scoring with ICM: the benchmarking results and strategies for improvement
Marco A. C. Neves et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2012)
REFMAC5 for the refinement of macromolecular crystal structures
Garib N. Murshudov et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2011)
Genetic Mechanisms of Antimicrobial Resistance of Acinetobacter baumannii
John S. Esterly et al.
ANNALS OF PHARMACOTHERAPY (2011)
Carbapenems: Past, Present, and Future
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Structures of the Class D Carbapenemase OXA-24 from Acinetobacter baumannii in Complex with Doripenem
Kyle D. Schneider et al.
JOURNAL OF MOLECULAR BIOLOGY (2011)
XDS
Wolfgang Kabsch
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Features and development of Coot
P. Emsley et al.
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY (2010)
Three Decades of beta-Lactamase Inhibitors
Sarah M. Drawz et al.
CLINICAL MICROBIOLOGY REVIEWS (2010)
Mechanistic Basis for the Emergence of Catalytic Competence against Carbapenem Antibiotics by the GES Family of β-Lactamases
Hilary Frase et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Extended-spectrum beta-lactamases: structure and kinetic mechanism
M. G. P. Page
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Inhibition of class A β-lactamases by carbapenems:: Crystallographic observation of two conformations of meropenem in SHV-1
Michiyosi Nukaga et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies
Matthew E. Falagas et al.
CRITICAL CARE (2006)
Critical involvement of a carbamylated lysine in catalytic function of class D β-lactamases
D Golemi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
